Summary

Psychedelics are back baby! Their effects on the brain are poised to revolutionise modern medicine.

Mind-altering substances have a long history in ancient ceremonies and rituals, before being banned in the tumultuous and risk-taking 1960s. Now they are providing new therapeutic hope in the management of medical conditions such as mental illness and addiction.

Find out how these drugs work, who might benefit and what is involved to get them back on the right side of the law, including the first psilocybin clinical trial to be approved in Australia.

FEATURING

Margaret Ross

Participant

Margaret Ross

Margaret Ross is a Senior Clinical Psychologist at St. Vincent's Hospital Melbourne, working in the Psychosocial Cancer Care and Palliative Medicine Departments. She has worked as a research fellow at...

View Profile

Olivia Carter

Participant

Olivia Carter

Olivia Carter is an Associate Professor at the University of Melbourne School of Psychological Sciences. She completed a PhD in neuroscience at The University of Queensland exploring the effects of...

View Profile

Matthew W. Johnson

Participant

Matthew W. Johnson

Matthew W. Johnson, PhD, is a Professor at Johns Hopkins and an expert on psychedelics, other drugs, and addiction. He has conducted research in behavioural pharmacology including psychedelics for >20...

View Profile

Paul Liknaitzky

Participant

Paul Liknaitzky

Paul Liknaitzky is a Research Fellow at Deakin University and Odyssey House Victoria. Paul has an Honours in Neuroscience and a PhD in Psychology from The University of Melbourne. His...

View Profile

Natasha Mitchell

Moderator

Natasha Mitchell

Natasha Mitchell is a multi-award winning radio host, science journalist, and podcaster with the Australian Broadcasting Corporation (ABC). She presents the weekly culture and science program, Science Friction, on ABC...

View Profile

View All Featured